Investing In Psychedelic Company Stocks isn’t Binary It’s Multifaceted
Did you know that the ‘shark’ investor, Mr. Kevin O’Leary was amongst the first businessperson to invest in psychedelic stocks? Initially, investors thought this investment to be a binary one. However, after the emergence of multiple start-ups that deal in research and preparation of authentic, FDA-approved psychoactive drugs, more capitalists joined stock market trading in psychedelic company stocks. One such player that entered the CSE in Feb’2021 is Bright Minds Biosciences (CSE: DRUG). It is a biotechnology company that houses expert scientists, drug designers, and professionals focused on redesigning the psilocybin (active ingredient in Magic Mushrooms) molecules. Their molecular designs diminish hallucinating effect of psilocybin. Thus, it maximizes its impact on patients with brain health disorders, neuropathy, and neurological illnesses. More Investors Seek To Trade-In Psychedelic Company Stocks After Canada, cities in the USA and the UK are also voting for psychedelic th...